PMID- 30368878 OWN - NLM STAT- MEDLINE DCOM- 20200330 LR - 20200330 IS - 1365-2265 (Electronic) IS - 0300-0664 (Linking) VI - 90 IP - 2 DP - 2019 Feb TI - No evidence of adverse fertility and pregnancy outcomes in patients with unrecognized and untreated multiple endocrine neoplasia type 1. PG - 312-319 LID - 10.1111/cen.13890 [doi] AB - OBJECTIVE: Literature concerning the impact of multiple endocrine neoplasia type 1 (MEN 1) on fertility is limited to case reports despite the early onset of endocrinopathies, such as primary hyperparathyroidism and prolactinoma, that may impact fertility. This study describes the impact of unrecognized and untreated MEN 1 on fertility and pregnancy outcomes in a multigenerational cohort of the Tasman 1 MEN 1 kindred. METHODS: All MEN 1 positive (MEN 1(+) , n = 63) and MEN 1 negative (MEN 1(-) , n = 75) descendants born between 1825 and 1951 of a common founder. Review of birth, death, marriage and medical records provided data on date of birth and death, gender, MEN 1 status and the number of pregnancies and children per parent. RESULTS: Compared to MEN 1(-) parents, MEN 1(+) parents had more children (RR 1.30, 1.02-1.66) and live births (RR 1.31, 1.02-1.67) with no excess of stillbirths (RR 1.24, 0.24-6.36). Compared to the era-matched Tasmanian fertility rate, MEN 1(+) parents had more children (4.87 +/- 4.11 vs 3.40 +/- 0.61, P = 0.048), whereas MEN 1(-) parents had similar numbers of children (3.67 +/- 3.27 vs 3.36 +/- 0.62, P = 0.55). MEN 1(+) parents had a similar number of MEN 1(+) and MEN 1(-) offspring (2.1 +/- 1.9 vs 2.5 +/- 2.3, P = 0.31). Indirectly assessed miscarriage rate was similar between MEN 1(+) and MEN 1(-) mothers (P = 0.77). Clinically overt pituitary disease reduced MEN 1(+) kindred member likelihood of parenthood (33% vs 97%). CONCLUSIONS: There was no adverse impact of MEN 1 on patient fertility overall; however, MEN 1-related pathology may have impaired the reproductive potential of a subset of individuals with pituitary disease. CI - (c) 2018 John Wiley & Sons Ltd. FAU - Thompson, Michael AU - Thompson M AUID- ORCID: 0000-0003-1425-5808 AD - School of Medicine, Department of Diabetes and Endocrinology, Royal Hobart Hospital, University of Tasmania, Hobart, Tasmania. FAU - Burgess, John AU - Burgess J AD - School of Medicine, Department of Diabetes and Endocrinology, Royal Hobart Hospital, University of Tasmania, Hobart, Tasmania. LA - eng PT - Journal Article DEP - 20181114 PL - England TA - Clin Endocrinol (Oxf) JT - Clinical endocrinology JID - 0346653 SB - IM MH - Birth Rate MH - Female MH - *Fertility MH - Humans MH - Live Birth MH - Multiple Endocrine Neoplasia Type 1/*physiopathology MH - Pituitary Diseases MH - Pregnancy MH - *Pregnancy Outcome MH - Retrospective Studies OTO - NOTNLM OT - fertility OT - multiple endocrine neoplasia type 1 OT - pregnancy EDAT- 2018/10/29 06:00 MHDA- 2020/03/31 06:00 CRDT- 2018/10/29 06:00 PHST- 2018/09/07 00:00 [received] PHST- 2018/10/14 00:00 [revised] PHST- 2018/10/22 00:00 [accepted] PHST- 2018/10/29 06:00 [pubmed] PHST- 2020/03/31 06:00 [medline] PHST- 2018/10/29 06:00 [entrez] AID - 10.1111/cen.13890 [doi] PST - ppublish SO - Clin Endocrinol (Oxf). 2019 Feb;90(2):312-319. doi: 10.1111/cen.13890. Epub 2018 Nov 14.